These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22388862)

  • 21. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
    Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
    Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge.
    Seo HW; Park C; Han K; Chae C
    Vet Res; 2014 Feb; 45(1):13. PubMed ID: 24484292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs.
    Opriessnig T; Xiao CT; Gerber PF; Halbur PG; Matzinger SR; Meng XJ
    J Gen Virol; 2014 Nov; 95(Pt 11):2495-2503. PubMed ID: 25053562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
    Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a PCV2d-2 isolate by experimental infection of pigs.
    Palya V; Homonnay ZG; Mató T; Kiss I
    Virol J; 2018 Nov; 15(1):185. PubMed ID: 30482219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms.
    Takahagi Y; Toki S; Nishiyama Y; Morimatsu F; Murakami H
    J Vet Med Sci; 2010 Jan; 72(1):35-41. PubMed ID: 19915335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.
    Fort M; Olvera A; Sibila M; Segalés J; Mateu E
    Vet Microbiol; 2007 Dec; 125(3-4):244-55. PubMed ID: 17611048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
    Shen HG; Halbur PG; Opriessnig T
    J Gen Virol; 2012 Jun; 93(Pt 6):1345-1355. PubMed ID: 22398315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of an interferon-stimulated response element (ISRE) mutant of porcine circovirus type 2 (PCV2) on PCV2-induced pathological lesions in a porcine reproductive and respiratory syndrome virus (PRRSV) co-infection model.
    Ramamoorthy S; Opriessnig T; Pal N; Huang FF; Meng XJ
    Vet Microbiol; 2011 Jan; 147(1-2):49-58. PubMed ID: 20637549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
    Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsid proteins from PCV2a genotype confer greater protection against a PCV2b strain than those from PCV2b genotype in pigs: evidence for PCV2b strains becoming more predominant than PCV2a strains from 2000 to 2010s.
    Huang L; Wang Y; Wei Y; Chen D; Liu D; Du W; Xia D; Wu H; Feng L; Liu C
    Appl Microbiol Biotechnol; 2016 Jul; 100(13):5933-43. PubMed ID: 27020283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commercially produced spray-dried porcine plasma contains increased concentrations of porcine circovirus type 2 DNA but does not transmit porcine circovirus type 2 when fed to naive pigs.
    Shen HG; Schalk S; Halbur PG; Campbell JM; Russell LE; Opriessnig T
    J Anim Sci; 2011 Jun; 89(6):1930-8. PubMed ID: 21278103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant.
    Juhan NM; LeRoith T; Opriessnig T; Meng XJ
    Virus Res; 2010 Jan; 147(1):60-6. PubMed ID: 19852989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication.
    Meerts P; Van Gucht S; Cox E; Vandebosch A; Nauwynck HJ
    Viral Immunol; 2005; 18(2):333-41. PubMed ID: 16035945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
    Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
    Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
    Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of porcine circovirus type 2 in swine populations in Canada and Costa Rica.
    Liu Q; Wang L; Willson P; O'Connor B; Keenliside J; Chirino-Trejo M; Meléndez R; Babiuk L
    Can J Vet Res; 2002 Oct; 66(4):225-31. PubMed ID: 12418777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental transmission of porcine circovirus type 2 (PCV2) in weaned pigs: a sequential study.
    Magar R; Larochelle R; Thibault S; Lamontagne L
    J Comp Pathol; 2000 Nov; 123(4):258-69. PubMed ID: 11041995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.